Arecor Therapeutics (AREC) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Mar 2024 08:58 AM
RNS
Arecor and TRx Biosciences research collaboration
12 Mar 2024 07:00 AM
RNS
Arecor and TRx Biosciences research collaboration
29 Feb 2024 07:00 AM
RNS
Arecor announces launch of Ogluo® in Netherlands
01 Feb 2024 07:00 AM
RNS
Year End Trading Update
23 Jan 2024 04:58 PM
RNS
Arecor announces update on INBRX-101
18 Jan 2024 07:00 AM
RNS
Arecor granted key European patent
08 Jan 2024 07:00 AM
RNS
Expansion of specialty hospital collaboration
03 Jan 2024 07:00 AM
RNS
Appointment of SVP for Tetris Pharma Ltd
04 Dec 2023 07:00 AM
RNS
Agreement with global medical products company
29 Nov 2023 07:00 AM
RNS
Arecor Continues Collaboration with Lilly
17 Nov 2023 07:00 AM
RNS
Product with Arestat technology launched in Europe
02 Nov 2023 07:00 AM
RNS
Inhibrx milestone triggers payment to Arecor
01 Nov 2023 03:31 PM
RNS
Exercise of rollover options & Total Voting Rights
02 Oct 2023 07:00 AM
RNS
Progress of Phase I clinical study of AT278
15 Sep 2023 07:00 AM
RNS
Arecor on Investor Meet Company Platform
14 Sep 2023 07:00 AM
RNS
Interim Results for six months ended 30 June 2023
07 Sep 2023 07:00 AM
RNS
Arecor: positive Hikma FDA pre-IND meeting
04 Sep 2023 07:00 AM
RNS
TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
17 Aug 2023 07:00 AM
RNS
Collaboration With Top 10 Global Pharma
10 Aug 2023 07:00 AM
RNS
Notice of Interim Results
20 Jul 2023 07:00 AM
RNS
Arecor Business Update
05 Jul 2023 07:00 AM
RNS
Additional Agreement with Leading Biopharma
27 Jun 2023 07:00 AM
RNS
Arecor granted key patents in Europe and China
26 Jun 2023 07:00 AM
RNS
Arecor presents positive data for AT247 at ADA
09 Jun 2023 03:35 PM
RNS
Exercise of rollover options & Total Voting Rights
09 Jun 2023 03:35 PM
RNS
Exercise of rollover options & Total Voting Rights
09 Jun 2023 12:43 PM
RNS
Result of AGM
09 Jun 2023 07:00 AM
RNS
AGM Statement
24 May 2023 07:00 AM
RNS
Director/PDMR Shareholding
15 May 2023 07:00 AM
RNS
TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
04 May 2023 04:00 PM
RNS
ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
26 Apr 2023 07:00 AM
RNS
Arecor Granted Key U.S Patent
21 Apr 2023 07:00 AM
RNS
Arecor on Investor Meet Company Platform
21 Apr 2023 07:00 AM
RNS
Arecor on Investor Meet Company Platform
20 Apr 2023 07:00 AM
RNS
Unaudited Preliminary Results for 2022
05 Apr 2023 07:00 AM
RNS
Arecor Appoints Chief Business Officer
22 Mar 2023 07:00 AM
RNS
FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
13 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
13 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
13 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
13 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
13 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
13 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
13 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
01 Mar 2023 07:00 AM
RNS
ARECOR TO PRESENT SHARESOC WEBINAR
24 Feb 2023 04:44 PM
RNS
Holding(s) in Company
24 Feb 2023 07:00 AM
RNS
Notice of Results
16 Feb 2023 07:00 AM
RNS
Arecor Granted Patents in India and the US
14 Feb 2023 07:01 AM
RNS
ARECOR STRENGTHENS COLLABORATION WITH PARTNER
30 Jan 2023 07:00 AM
RNS
Arecor Publishes Data for AT278 in Diabetes Care
UK 100

Latest directors dealings